Deutsche Bank Reaffirms Their Buy Rating on Novo Nordisk (0QIU)
In a report released on October 10, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research ...
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock
One of the hottest areas of the pharmaceutical world right now revolves around blockbuster medications used to treat diabetes ...
3 No-Brainer Growth Stocks to Buy in October
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Novo Nordisk CEO Lars Jorgensen blames ‘complex US healthcare system’ for steep Ozempic prices — which Senator Bernie Sanders says may lead to higher insurance …
Novo Nordisk CEO Lars Fruergaard Jorgensen has called attention to the complexities of the U.S. healthcare system while ...
India’s copycat drugmakers gear up to offer cheaper weight-loss drugs
Expiry of Novo Nordisk’s UK patent for Saxenda seen as offering a ‘dry run’ for future generic versions of Ozempic ...
Balding man unrecognisable after 'amazing' transformation as admirers say 'he looks so much younger'
The 26-year-old popped in for a visit at a salon in North East England but little did he know he would return a new man with ...
en.mehrnews3h
Russia to rebuild everything destroyed in Donbas, Novorossiy
Russia will create conditions to realize the agricultural potential of Donbas and Novorossiya and will restore all the ...
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...
The American Journal of Managed Care1h
In Wake of Express Scripts Suit, FTC Takes On 3 Largest PBMs
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Weight loss drugs have one big issue; These companies want to fix it
Read which pharmaceutical companies are addressing the risk of muscle mass loss associated with popular weight loss drugs from Novo (NOVO) and Eli Lilly (LLY).
Pfizer Fizzes Out: From Pandemic Pandemonium To Stunted Growth
Apart from mistrust in the larger pharmaceutical world and Pfizer's inability to find a major break after the pandemic ...